Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T15:05:36.881Z.
Calculation as of: 2026-10-06T15:05:36.881Z.
Quote observation: 2026-10-06T15:04:59.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$803.27M
Operating Cash Flow Yield
11.03%
TTM Avg
10.22%
3Y Avg
10.24%
5Y Avg
8.00%
Market Cap
$797.15M
Operating Cash Flow Yield
N/A
TTM Avg
0.41%
3Y Avg
2.06%
5Y Avg
3.27%
Market Cap
$821.37M
Operating Cash Flow Yield
N/A
TTM Avg
26.54%
3Y Avg
24.23%
5Y Avg
24.23%
Market Cap
$787.07M
Operating Cash Flow Yield
74.11%
TTM Avg
47.32%
3Y Avg
42.03%
5Y Avg
31.48%
Market Cap
$828.30M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$777.20M
Operating Cash Flow Yield
N/A
TTM Avg
1.73%
3Y Avg
1.73%
5Y Avg
1.73%
Market Cap
$777.34M
Operating Cash Flow Yield
N/A
TTM Avg
46.70%
3Y Avg
46.70%
5Y Avg
28.34%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Apnimed, Inc. (APMD) | $802.84M | N/A | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $803.27M | 11.03% | 10.22% | 10.24% | 8.00% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $797.15M | N/A | 0.41% | 2.06% | 3.27% |
| Ardelyx, Inc. (ARDX)vs › | $821.37M | N/A | 26.54% | 24.23% | 24.23% |
| AdaptHealth Corp. (AHCO)vs › | $787.07M | 74.11% | 47.32% | 42.03% | 31.48% |
| Jade Biosciences, Inc. (JBIO)vs › | $828.30M | N/A | N/A | N/A | N/A |
| Alumis Inc. (ALMS)vs › | $838.73M | N/A | N/A | N/A | N/A |
| Geron Corporation (GERN)vs › | $777.20M | N/A | 1.73% | 1.73% | 1.73% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $777.34M | N/A | 46.70% | 46.70% | 28.34% |
| Beta Bionics, Inc. (BBNX)vs › | $835.48M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
